All news

Faculty / Service
Group
Keyword
Abstract shapes of women
University of Ottawa Heart Institute
Equity, diversity and inclusion
Research and innovation

International Women’s Day Q&A with Dr. Katey Rayner

Dr. Katey Rayner is one of our research community’s dynamic leaders.
Dr. Katey Rayner is one of our research community’s dynamic leaders.

March 6, 2024
Female researchers in lab, looking through microscope
Newsroom
Faculty of Medicine
Medicine
Cellular and Molecular Medicine
Research and innovation

Study: How nutrients are used reprograms immune cells with implications for infection and cancer

Research from the Faculty of Medicine suggests immune and non-immune cells can be reprogrammed by changing how nutrients are used. These insights may prove to have ramifications for battling cancer.
Research from the Faculty of Medicine suggests immune and non-immune cells can be reprogrammed by changing how nutrients are used. These insights may prove to have ramifications for battling cancer.

October 5, 2023
Reflection off astronaut's visor
Newsroom
Research and innovation
Faculty of Medicine
Health

Space travel depletes red blood cells and bone, but bone marrow fat may come to the rescue

A study of 14 astronauts suggests that while space travel depletes red blood cells and bone, the body can eventually replenish them back on Earth with the help of fat stored in the bone marrow. The study, published in Nature Communications, has important implications for health in space and on Earth.
A study of 14 astronauts suggests that while space travel depletes red blood cells and bone, the body can eventually replenish them back on Earth with the help of fat stored in the bone marrow. The study, published in Nature Communications, has important implications for health in space and on Earth...

August 21, 2023
Graphic illustrating process of research
Newsroom
Faculty of Medicine
Research and innovation
Health
Medicine

Healing power of light: uOttawa team advances clear vision for eye repair

With potential to impact millions, study finds that biomimetic materials pulsed with low-energy blue light can reshape damaged corneas, including thickening the tissue.
With potential to impact millions, study finds that biomimetic materials pulsed with low-energy blue light can reshape damaged corneas, including thickening the tissue.

July 25, 2023
Drug discovery
Research and innovation
Faculty of Medicine
Newsroom

uOttawa team develops new drug discovery platform

The comprehensive screening platform and cellular interrogation tool has the potential to facilitate novel drug discovery targeting a slew of human diseases.
The comprehensive screening platform and cellular interrogation tool has the potential to facilitate novel drug discovery targeting a slew of human diseases.

July 5, 2023
vector illustration of heart and brain
Funding

The Heart & Stroke Foundation of Canada funds innovative Heart Institute research

The Heart & Stroke Foundation of Canada (Heart & Stroke) named four researchers from the University of Ottawa Heart Institute recipients of project funding through its Grant-in-Aid Program.
The Heart & Stroke Foundation of Canada (Heart & Stroke) named four researchers from the University of Ottawa Heart Institute recipients of project funding through its Grant-in-Aid Program.

June 1, 2023
a researcher using a microscope
Faculty of Medicine

Greener lab research: our cancer researchers are leading the way

We need lab research to understand the diseases of today and find the treatments of tomorrow. But like other areas of healthcare, it creates a lot of waste and uses a lot of energy.
We need lab research to understand the diseases of today and find the treatments of tomorrow. But like other areas of healthcare, it creates a lot of waste and uses a lot of energy.

April 18, 2023
FoM Logo with purple background
Funding
Financial aid and awards

Bringing cellular immunotherapy to solid tumours: made-in-Canada approach to be pioneered in biliary tract cancers thanks to $7.4M grant

Canadians with biliary tract cancer (cholangiocarcinoma and gallbladder) will have the first chance to benefit from a new made-in-Canada approach to personalized cellular immunotherapy, thanks to a $7.4 million grant from the Canadian Cancer Society and the Canadian Institutes of Health Research.
Canadians with biliary tract cancer (cholangiocarcinoma and gallbladder) will have the first chance to benefit from a new made-in-Canada approach to personalized cellular immunotherapy, thanks to a $7.4 million grant from the Canadian Cancer Society and the Canadian Institutes of Health Research.

April 13, 2023